TABLE 2.
Patient and tumor characteristics.
| Age (year) | 63.52 ± 9.4 (37–84) | Grade | |
|---|---|---|---|
| Gravidity | 2.28 ± 1.47 (0–10) | Low | 26 (27.1%) |
| Parity | 1.69 ± 0.93 (0–4) | High | 70 (72.9%) |
| Postmenopause | 91 (94.8%) | Treatment | |
| Histologic subtype | |||
| Endometrioid adenocarcinoma | 90 (93.7%) | Adjuvant irradiation | 87 (90.6%) |
| Serous adenocarcinoma | 6 (6.3%) | Adjuvant chemoirradiation | 4 (4.1%) |
| Adjuvant chemotherapy (due to recurrence or metastases) | 3 (3.1%) | ||
| Positive lymph node status | 26 (27.1%) | Recurrence and/or metastasis | 8 (8.3%) |
Age, gravidity, parity: mean, SD, range. Postmenopausal state, Histopathologic subtype, Grade, Treatment, Recurrence, and metastasis: frequency (%).